These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15919683)
1. Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Shafqat A; Einhorn LH; Hanna N; Sledge GW; Hanna A; Juliar BE; Monahan P; Bhatia S Ann Oncol; 2005 Sep; 16(9):1545-50. PubMed ID: 15919683 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year. Ferrando SJ; Rabkin JG; Poretsky L J Acquir Immune Defic Syndr; 1999 Oct; 22(2):146-54. PubMed ID: 10843528 [TBL] [Abstract][Full Text] [Related]
3. The relationship between interleukin-6, tumor necrosis factor-α, and fatigue in terminally ill cancer patients. Kwak SM; Choi YS; Yoon HM; Kim DG; Song SH; Lee YJ; Yeom CH; Koh SJ; Park J; Lee MA; Suh SY Palliat Med; 2012 Apr; 26(3):275-82. PubMed ID: 21807751 [TBL] [Abstract][Full Text] [Related]
4. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). Suleiman K; Al Kalaldeh M; AbuSharour L; Yates B; Berger A; Mendoza T; Malak M; Salameh AB; Cleeland C; Menshawi A East Mediterr Health J; 2019 Nov; 25(11):784-790. PubMed ID: 31782514 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Amharic Version of the Brief Fatigue Inventory for Assessment of Cancer-Related Fatigue in Ethiopian Cancer Patients. Gebremariam GT; Anshabo AT; Tigeneh W; Engidawork E J Pain Symptom Manage; 2018 Aug; 56(2):264-272. PubMed ID: 29753101 [TBL] [Abstract][Full Text] [Related]
6. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Dev R; Hui D; Del Fabbro E; Delgado-Guay MO; Sobti N; Dalal S; Bruera E Cancer; 2014 May; 120(10):1586-93. PubMed ID: 24577665 [TBL] [Abstract][Full Text] [Related]
7. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. Paramita N; Nusdwinuringtyas N; Nuhonni SA; Atmakusuma TD; Ismail RI; Mendoza TR; Cleeland CS J Pain Symptom Manage; 2016 Nov; 52(5):744-751. PubMed ID: 27660081 [TBL] [Abstract][Full Text] [Related]
8. The Brief Fatigue Inventory is reliable and valid for the burn patient cohort. Toh C; Li M; Finlay V; Jackson T; Burrows S; Wood FM; Edgar DW Burns; 2015 Aug; 41(5):990-7. PubMed ID: 25499405 [TBL] [Abstract][Full Text] [Related]
9. A comparison of three fatigue measures in veterans with cancer. Hwang SS; Chang VT; Kasimis BS Cancer Invest; 2003 Jun; 21(3):363-73. PubMed ID: 12901282 [TBL] [Abstract][Full Text] [Related]
10. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Cleare AJ; O'Keane V; Miell JP Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Taiwanese version of the Brief Fatigue Inventory. Lin CC; Chang AP; Chen ML; Cleeland CS; Mendoza TR; Wang XS J Pain Symptom Manage; 2006 Jul; 32(1):52-9. PubMed ID: 16824985 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Induced Fatigue Correlates With Higher Fatigue Scores Before Treatment. Araújo JKL; Giglio AD; Munhoz BA; Fonseca FLA; Cruz FM; Giglio AD Am J Hosp Palliat Care; 2017 Jun; 34(5):404-411. PubMed ID: 26847709 [TBL] [Abstract][Full Text] [Related]
13. Validation study of the Japanese version of the brief fatigue inventory. Okuyama T; Wang XS; Akechi T; Mendoza TR; Hosaka T; Cleeland CS; Uchitomi Y J Pain Symptom Manage; 2003 Feb; 25(2):106-17. PubMed ID: 12590026 [TBL] [Abstract][Full Text] [Related]
14. Measurement of Cancer-Related Fatigue Based on Heart Rate Variability: Observational Study. Shih CH; Chou PC; Chou TL; Huang TW J Med Internet Res; 2021 Jul; 23(7):e25791. PubMed ID: 36260384 [TBL] [Abstract][Full Text] [Related]
15. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. Friedrich N; Völzke H; Rosskopf D; Steveling A; Krebs A; Nauck M; Wallaschofski H J Androl; 2008; 29(6):610-7. PubMed ID: 18599883 [TBL] [Abstract][Full Text] [Related]
16. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Waggoner W; Boots LR; Azziz R Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333 [TBL] [Abstract][Full Text] [Related]
17. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Morley JE; Kaiser F; Raum WJ; Perry HM; Flood JF; Jensen J; Silver AJ; Roberts E Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7537-42. PubMed ID: 9207127 [TBL] [Abstract][Full Text] [Related]
19. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Ahboucha S; Pomier-Layrargues G; Vincent C; Hassoun Z; Tamaz R; Baker G; Butterworth RF Neurochem Int; 2008; 52(4-5):569-74. PubMed ID: 17669554 [TBL] [Abstract][Full Text] [Related]
20. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). Wang XS; Hao XS; Wang Y; Guo H; Jiang YQ; Mendoza TR; Cleeland CS J Pain Symptom Manage; 2004 Apr; 27(4):322-32. PubMed ID: 15050660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]